Clinical Trial Update: Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis B [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing telbivudine to lamivudine for chronic hepatitis B was withdrawn from the study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Lamivudine (lamivudine)
• Telbivudine (telbivudine)

Snippet

Sponsor: University of Ulm | Conditions: Hepatitis B, Chronic | Phase 4 | Status: WITHDRAWN